November 11, 2025
Influencers in Pharma: A Growing Compliance Frontier
Ensure FDA-compliant pharma influencer campaigns with insights on OPDP rules, risk disclosure, platform challenges, and sponsor oversight responsibilities.
ProPharma offers global Clinical Quality Assurance consulting to ensure inspection readiness and regulatory compliance across pharmaceutical, biologics, and medical device sectors. Our experienced QA professionals deliver end-to-end support—from GCP audits, SOP development, and CAPA management to trial oversight and mock inspections—tailored to your needs in every region. Wherever your clinical programs operate, we help you maintain quality, integrity, and confidence.
A strong Clinical Quality Assurance (CQA) framework is essential for maintaining the integrity, reliability, and compliance of clinical programs. Our CQA services provide proactive to reactive quality support to sponsors and CROs, ensuring adherence to regulatory standards and industry best practices. Ensure Clinical Quality & Compliance with Expert Support.

Oversight and compliance support for CROs, investigator sites, central labs, pharmacies, animal/toxicology studies, SaaS providers, and other vendors to ensure regulatory adherence and performance.
Identifying and resolving clinical trial issues to mitigate risks and improve study outcomes.
Thorough assessments of Trial Master Files to ensure completeness, accuracy, and regulatory compliance.
Tailored support to address specific clinical quality challenges and operational needs.
A structured auditing approach is essential for identifying compliance gaps, mitigating risks, and ensuring regulatory readiness. Our clinical auditing services help organizations maintain compliance with global regulatory expectations.
Regulatory inspections can be complex and high-stakes. Our inspection readiness services ensure your organization is fully prepared to meet global regulatory expectations with confidence.
A well-structured Clinical Sponsor Quality Management System (QMS) is essential for regulatory compliance, operational efficiency, and risk mitigation. At ProPharma, we help sponsors design, implement, and optimize QMS frameworks tailored to their clinical study and organizational needs.
The process begins with a kick-off meeting to ensure alignment with our client and key stakeholders to review unique requirements to consider.
Moving into the execution phase, we assess and implement QMS improvements:

Evaluating your current QMS and scaling solutions to fit your organization’s size, scope, and regulatory requirements.
Creating and refining policies, SOPs, and quality documents to ensure compliance with industry standards.
Supporting the seamless integration of quality management systems across your operations.
Providing in-depth training on QMS best practices, regulatory expectations, and continuous improvement strategies.
Whether you're building a new QMS or enhancing an existing system, our experts provide tailored solutions to ensure compliance and efficiency.
At ProPharma, we provide expert clinical consulting services to medical device and diagnostics companies. Helping to navigate and ensure compliance to complex global regulatory requirements while achieving operational excellence.
Our team specializes in supporting the unique requirements of medical device companies in meeting international compliance standards, including:
Partner with us for expert clinical compliance and quality solutions. Contact ProPharma today to learn how we can support your organization's Clinical Quality Assurance needs.
November 11, 2025
Ensure FDA-compliant pharma influencer campaigns with insights on OPDP rules, risk disclosure, platform challenges, and sponsor oversight responsibilities.
November 6, 2025
Discover how non-European pharma companies can quickly and compliantly secure EU/UK Marketing Authorisation Holder status without local infrastructure, ensuring market success.
July 8, 2025
ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...
January 31, 2025
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.
January 31, 2025
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.
October 9, 2024
ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.
November 7, 2025
U.S. tariff policies are shifting fast and pharma companies dependent on global supply chains are feeling the strain. With new tariffs on APIs, excipients, and finished drug products climbing as high...
November 5, 2025
Artificial intelligence (AI) is no longer a future concept — it’s transforming Medical Information (MI) today. In a field where accuracy, empathy, and speed define trust, AI is emerging not just as a...
October 30, 2025
In today’s data-driven pharmaceutical landscape, patient safety depends on more than vigilance — it demands collaboration. Pharmacovigilance and Medical Information teams are no longer operating in...
November 18, 2025
Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...
November 11, 2025
Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...
November 7, 2025
U.S. tariff policies are shifting fast and pharma companies dependent on global supply chains are feeling the strain. With new tariffs on APIs, excipients, and finished drug products climbing as high...
November 5, 2025
Artificial intelligence (AI) is no longer a future concept — it’s transforming Medical Information (MI) today. In a field where accuracy, empathy, and speed define trust, AI is emerging not just as a...
October 30, 2025
In today’s data-driven pharmaceutical landscape, patient safety depends on more than vigilance — it demands collaboration. Pharmacovigilance and Medical Information teams are no longer operating in...
November 18, 2025
Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...